These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 19426196
1. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome. Stern JM, Gupta A, Raman JD, Cost N, Lucas S, Lotan Y, Raj GV, Cadeddu JA. BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196 [Abstract] [Full Text] [Related]
2. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA. BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900 [Abstract] [Full Text] [Related]
3. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes. Raman JD, Thomas J, Lucas SM, Bensalah K, Lotan Y, Trimmer C, Cadeddu JA. Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445 [Abstract] [Full Text] [Related]
4. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. Ma Y, Bedir S, Cadeddu JA, Gahan JC. BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553 [Abstract] [Full Text] [Related]
5. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA. BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136 [Abstract] [Full Text] [Related]
6. Radiofrequency ablation of renal tumors in the solitary kidney. Krambeck AE, Farrell MA, Callstrom MR, Atwell TD, Charboneau JW, Chow GK, Dimarco DS, Patterson DE. Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143 [Abstract] [Full Text] [Related]
7. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Cancer; 2010 Jul 01; 116(13):3135-42. PubMed ID: 20564644 [Abstract] [Full Text] [Related]
8. Partial nephrectomy in two patients with known T3a tumours involving the renal vein. Kim EH, Jain S, Benway BM, Figenshau RS. BJU Int; 2012 May 01; 109(9):1345-8. PubMed ID: 21883846 [Abstract] [Full Text] [Related]
9. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. Levinson AW, Su LM, Agarwal D, Sroka M, Jarrett TW, Kavoussi LR, Solomon SB. J Urol; 2008 Aug 01; 180(2):499-504; discussion 504. PubMed ID: 18550123 [Abstract] [Full Text] [Related]
10. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG. BJU Int; 2012 May 01; 109(10):1450-6. PubMed ID: 22221502 [Abstract] [Full Text] [Related]
11. Radiofrequency ablation of renal cell carcinoma: a follow up of outcomes. Curry D, Yassin M, Thwaini A, Pahuja A, Alanbuki AH, Rajan TN, Loan W. Can J Urol; 2014 Feb 01; 21(1):7135-40. PubMed ID: 24529016 [Abstract] [Full Text] [Related]
12. Outcome of nephron-sparing surgery for T1b renal cell carcinoma. Joniau S, Vander Eeckt K, Srirangam SJ, Van Poppel H. BJU Int; 2009 May 01; 103(10):1344-8. PubMed ID: 19040528 [Abstract] [Full Text] [Related]
13. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein. Woldu SL, Barlow LJ, Patel T, Hruby GW, Benson MC, McKiernan JM. Urology; 2010 Sep 01; 76(3):639-42. PubMed ID: 20163841 [Abstract] [Full Text] [Related]
14. Functional and oncological outcomes of partial nephrectomy of solitary kidneys. La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A. J Urol; 2009 May 01; 181(5):2037-42; discussion 2043. PubMed ID: 19298974 [Abstract] [Full Text] [Related]
15. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses. Sung HH, Park BK, Kim CK, Choi HY, Lee HM. Int J Hyperthermia; 2012 May 01; 28(3):227-34. PubMed ID: 22515344 [Abstract] [Full Text] [Related]
16. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney. Berdjis N, Hakenberg OW, Novotny V, Manseck A, Oehlschläger S, Wirth MP. Scand J Urol Nephrol; 2007 May 01; 41(1):10-3. PubMed ID: 17366096 [Abstract] [Full Text] [Related]
17. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G, Laganà D, Ianniello A, Mangini M, Fontana F, Cotta E, Concollato L, Marconi A, Recaldini C, Dionigi G, Rovera F, Boni L, Cuffari S, Fugazzola C. Int J Surg; 2008 May 01; 6 Suppl 1():S31-5. PubMed ID: 19200792 [Abstract] [Full Text] [Related]
18. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours. Kim EH, Tanagho YS, Bhayani SB, Saad NE, Benway BM, Figenshau RS. BJU Int; 2013 May 01; 111(6):872-9. PubMed ID: 23145500 [Abstract] [Full Text] [Related]
19. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience. Nitta Y, Tanaka T, Morimoto K, Makino T, Nishikawa N, Tashiro K, Naganuma T, Iguchi T, Matsuoka T, Nakatani T. Anticancer Res; 2012 Feb 01; 32(2):615-8. PubMed ID: 22287753 [Abstract] [Full Text] [Related]
20. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up. Denzinger S, Ganzer R, Fink A, Wieland WF, Blana A. Scand J Urol Nephrol; 2007 Feb 01; 41(6):496-500. PubMed ID: 17853016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]